Background: Current guidelines advise using echocardiography for noninvasive estimation of the likelihood that a patient has pulmonary hypertension (PH). To estimate the echocardiographic probability of PH, the maximal tricuspid regurgitation velocity (TR Vmax) is recommended as the main parameter to use over more complex algorithms that provide an estimation of pulmonary artery pressure. This preference is based on concerns about inaccuracies and amplification of measurement errors that can occur from using derived variables. However, this has not been examined systematically.
Pulmonary hypertension (PH) is defined as a mean pulmonary artery pressure (PAPm) of $25 mm Hg at rest as assessed by right heart catheterization (RHC).
1,2 Although a definite diagnosis of PH requires invasive assessment of PAPm, noninvasive estimation of PAPm from Doppler measurements obtained by transthoracic echocardiography may help either suggest a preliminary diagnosis of PH or make it unlikely. Thus, echocardiography is a Class 1C recommended first-line, noninvasive diagnostic investigation in cases of suspected PH. 1 Furthermore, noninvasive echocardiographic estimation of PAPm may be used to follow and monitor treatment effects in patients with definite PH. The results obtained from echocardiographic examination in combination with the degree of clinical suspicion of PH should be used to define the probability of PH and to determine the need for RHC in an individual patient. 1 Commonly used methods for estimating PAPm are based on the Doppler-derived velocity-time integral of tricuspid regurgitation (TR). [3] [4] [5] [6] [7] [8] PAPm can be calculated by adding the right atrial-right ventricular mean gradient (TR Pmean) to estimated right atrial pressure (RAP). [3] [4] [5] Alternatively, various empirical formulas for calculating PAPm from the TRderived systolic pulmonary artery pressure (PAPsys) have been described. [6] [7] [8] [9] [10] However, all TR-based methods for estimating PAPm require estimation of RAP. Alternatively, such as in cases of weak TR signal (no or only trace TR), PAPm may be calculated independently of TR signals using pulmonary acceleration time (PAT) of the pulmonary artery flow as measured by pulsed Doppler ultrasonography. 3, 11, 12 The 2015 European Society of Cardiology (ESC) and European Respiratory Society guidelines for the diagnosis and treatment of PH recommend continuouswave Doppler measurement of maximal TR velocity (TR Vmax; not estimated PAPsys or PAPm) as the main variable to use in determining the echocardiographic probability of PH. 1 The reason for this preference according to the guidelines is ''the inaccuracies of RAP estimation and the amplification of measurement errors by using derived variables.'' However, although these guidelines highlight the impact of echocardiography for estimating the probability of PH, whether the extent of such inaccuracies fully support a preference for TR Vmax was not examined previously. Hence, the best method for assigning the likelihood of PH or noninvasively estimating PAPm is not known. Therefore, we examined the accuracy of various approaches for estimating PAPm and additional parameters, including the TR Vmax method, in a retrospective analysis of unselected patients who underwent echocardiography and RHC.
METHODS

Study Design, Study Population, and Definitions
We retrospectively reviewed echocardiographic examinations and the results of RHC performed at the Clinic for Cardiology and Pneumology, University Medical Center G€ ottingen; King's College Hospital, London; and the Department of Internal Medicine II, University of Regensburg between 2011 and 2016. In all cases, the maximal interval between echocardiography and cardiac catheterization was 24 hours. The study was conducted as a database search limited to echocardiographic and RHC data as approved by the local ethics committees and in accordance to the amended Declaration of Helsinki. All data relevant to this analysis were subjected to careful review by an experienced imaging specialist who was blinded to the results of the invasive pulmonary pressure measurements. As part of this review, any echocardiographic reading that was suboptimal was remeasured (using Philips Xcelera/TomTec software, Philips, Amsterdam, The Netherlands), and any image (and associated readings) of insufficient quality were excluded from the analysis. The definition of PH and further classification of PH were based on the 2015 ESC guidelines for the diagnosis and treatment of PH: PH was defined as PAPm $ 25 mm Hg as assessed at rest by RHC. 1 When PH was diagnosed, it was further classified as precapillary (pulmonary capillary wedge pressure # 15 mm Hg), combined pre-and postcapillary (pulmonary capillary wedge pressure > 15 mm Hg and diastolic pressure gradient $ 7 mm Hg), or isolated postcapillary (pulmonary capillary wedge pressure > 15 mm Hg and diastolic pressure gradient < 7 mm Hg). 1 To identify the best method for noninvasively estimating PAPm, various TR-derived or PAT-derived approaches were compared, as detailed in Table 1 and Figure 1 . In brief, continuous-wave Doppler ultrasonography of TR in apical four-chamber and parasternal short-axis views was applied, and the TR time-velocity tracing was determined to obtain the time-velocity integral, TR Vmax, mean TR velocity, maximal right atrial-right ventricular gradient, and TR Pmean. Patients without or with very weak continuous-wave Doppler signals that did not allow clear determination of the timevelocity signal (such as patients without or with only trace TR) were excluded from the analysis that relied on TR signals. (The application of agitated saline contrast for enhancing weak TR signals was not a part of the standard operational procedures.)
In all other patients, PAPm was calculated either according to Aduen et al 4 by adding estimated RAP to TR Pmean obtained from tracing of the TR time-velocity integral or by empirical formulas for the calculation of PAPm from PAPsys (Table 1) . [6] [7] [8] [9] [10] PAPsys was calculated by adding estimated RAP to TR Pmax. 3 RAP was estimated by measuring the diameter of the inferior vena cava (IVC) at endexpiration and the inspiratory collapsibility in the subcostal view as follows: when the IVC diameter was #21 mm and the collapsibility with a sniff was >50%, RAP was estimated to be 3 mm Hg; when the IVC diameter was >21 mm and the collapsibility was <50%, RAP was estimated to be 15 mm Hg. In all other cases (either IVC diameter >21 mm and collapse >50% or IVC diameter #21 mm and collapse <50%), RAP was estimated to be 8 mm Hg. 3, 13 To estimate PAPm independent of the measurements of TR (and RAP), PAT was measured as previously described. 11, 12, 14, 15 In brief, the pulmonary artery was visualized in the parasternal short-axis view. The sample volume of the pulsed-wave Doppler was then placed about 1 cm distal to the open leaflet tips of the pulmonary valve in parallel orientation to the axis of blood flow. PAT was measured from the onset of ejection to the peak flow velocity.
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All echocardiographic dimensions were obtained from twodimensional images (B-mode).
Data Analysis and Statistical Methods
Continuous variables are presented as median values with the corresponding 25th and 75th percentiles. Comparisons of continuous variables were performed using the Mann-Whitney U test. Proportions are expressed as percentages and as absolute numbers. Categorical variables were compared using the Fisher exact test. To test for correlations between estimated PAPm and invasively measured PAPm, the Spearman coefficient was calculated. CIs were obtained by nonparametric bootstrapping, with 9,999 bootstrap replications. 16 The Spearman correlation coefficients of various echocardiographic variables with invasive PAPm were tested for differences using the approach by Steiger. Chemla et al, 6 Steckelberg et al, 9 and Amsallem et al 10 used similar formulas to estimate PAPm from PAPsys. Of those, only the formula proposed by Chemla et al (which was the first one) was used for analysis in our study. ‡ Chemla et al and Syyed et al 7 did not perform echocardiographic examinations. Thus, the relationship between PAPsys and PAPm was derived solely from invasive measurements. § Yared et al 14 did not perform RHCs. Thus, the relationship between PAPsys and PAPm was derived solely from echocardiographic measurements.
Journal of the American Society of Echocardiography Volume 31 Number 1 methods to noninvasively estimate PAPm. Receiver operating characteristic (ROC) analysis served to calculate the area under the curve (AUC) for noninvasive PAPm estimations, TR Vmax, and PAPsys. CIs were derived on the basis of the asymptotic normality of AUC. Youden index quantification was used to determine the optimal cohort-specific cutoff values. The ROC curves were tested for differences using the approach of DeLong et al. 18 Using logistic regression analyses, the odds ratios (ORs) of noninvasive PAPm estimations, TR Vmax, PAPsys, and right ventricular size and function were calculated with regard to the likelihood of PH with 95% CIs also presented. Non-nested logistic regression models were compared using Clarke's test. 19 According to guideline recommendations, reference values were <25 mm Hg for PAPm, <2.8 m/sec for TR Vmax, <100 msec for PAT, and <35 mm Hg for PAPsys. Data were analyzed using SPSS version 22.0 (SPSS, Chicago, IL) and SAS version 9.4 (SAS Institute, Cary, NC). Statistical tests were two tailed and used a significance level of P < .05.
RESULTS
Overall, 90 patients with a maximum time frame of 24 hours between RHC and echocardiographic examination were identified. The median time frame was 18.8 hours (7.6-21.7 hours). Baseline characteristics, echocardiographic findings, and results of RHC are summarized in the online supplement (Supplemental Table 1 ). In brief, the mean age was 64.8 years (55.0-78.0 years), and 52.4% of patients were women. PH as determined by RHC was present in 68 patients (75.6%). Of these, 17 patients (25.0%) had precapillary, 11 patients (21.6%) had combined pre-and postcapillary, and 40 patients (58.8%) had isolated postcapillary PH. The median PAPm was 35.0 mm Hg (24.7-46.2 mm Hg). There was a near Gaussian distribution of invasively measured PAPm values (Figure 2 ).
Echocardiographic Estimation of PAPm
Echocardiographic examinations were reviewed with regard to the presence and quality of continuous-wave Doppler measurements of the TR jet and pulsed-wave Doppler measurements of PAT. Thirteen patients (14.4%) had no or insufficient TR signals and were therefore excluded from analysis of the TR-derived methods. Four patients were excluded from the PAT measurements because of insufficient image quality. PAT was adequately measured in 46 patients (51.1%). The median echocardiographically determined PAPm was 32.5 mm Hg (25.2-44.1 mm Hg), 34.9 mm Hg (26.9-45.0 mm Hg), and 37.3 mm Hg (26.3-44.1 mm Hg), according to the methods described by Aduen et al, 4 Chemla et al, 6 and Dabestani et al, 11 respectively (Figure 2 ; additional empirical formulas of Friedberg et al 8 and Syyed et al 7 yielded similar results to those determined using the formula of Chemla et al). Interestingly, the PAT method seemed to underestimate the highest values systematically (compare Figures 2A and 2F) , whereas the other algorithms adequately represented invasively determined maximal values. Journal
Correlations of Different Methods with Invasive mPAP and Bland-Altman Analysis
All analyzed noninvasive methods for estimating PAPm significantly correlated with invasively determined PAPm (Figure 3 ). The direct estimation of PAPm using the method of Aduen et al 4 had the greatest correlation coefficient (r = 0.731, P < .001). Importantly, despite the guideline preference for TR Vmax, the correlation of TR Vmax with invasively determined PAPm was significantly lower compared with the correlations of various other echocardiographic variables with invasive PAPm (Aduen et al, P < .02; Chemla et al, 6 P < .01; Friedberg et al, 8 P < .01; Syyed et al, 7 P < .01; Rudski et al,
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P < .01) except for the method of Dabestani et al 11 (P = .12). The PAT-derived method showed only a weak but statistically significant correlation with invasively determined PAPm. Of note, estimated RAP and invasively determined RAP were correlated moderately (r = 0.592, P < .001). A corresponding scatterplot is provided in the online supplement (Supplemental Figure 1) .
To determine the degree of agreement between invasively measured PAPm and different approaches for noninvasively estimating PAPm, we performed a Bland-Altman analysis (Figure 4 ). For all examined methods, the mean value of the difference between invasively measured PAPm and noninvasively measured PAPm was near zero. The limits of agreement (mean value 6 1.96 Â SD) were in the range of 620 mm Hg for the method of Aduen et al To examine whether differences in the timing of echocardiography and RHC might account for less accurate correlations, we conducted a separate analysis according to the method of Aduen et al 4 for the subgroup of patients with delays of >12 but #24 hours. For this subgroup, PAPm still had a good correlation with the invasively measured PAPm (r = 0.835, P < .001), suggesting that a short time delay between echocardiographic and invasive measurements does not substantially affect correlation. In patients with severe TR, TR velocity may be underestimated, and guideline recommendations emphasize that TR velocity cannot be used to exclude PH in such cases. However, in our subset of patients with severe TR (n = 16), the correlation of RHC with the TR-based method of Aduen et al was preserved and was statistically significant (r = 0.720, P = .002).
Performance of Different Methods for Determining the Likelihood of PH
In the ROC analysis with regard to invasively confirmed PH, we observed the best test performance using the algorithm of Aduen et al 4 (AUC = 0.851, P < .001; Figure 5 ). Moreover, compared with TR Vmax, the method of Aduen et al revealed significantly better performance (AUC = 0.851 vs 0.718, P < .05). Among the various empirical methods, results were essentially identical. Not surprisingly, because of only marginal differences regarding the three formulas, all three methods yielded similar AUCs and P values. Of note, using Youden index quantification, the optimal cutoff value for our cohort was 2.9 m/sec for the TR Vmax method and 25.95 mm Hg for the PAPm method. Because these values were very close to the cutoff values in the guidelines, the latter were used for analysis of ORs. ORs with regard to the presence of PH are summarized in Table 2 . Figure 4 Bland-Altman analysis of different methods for estimating mean pulmonary artery pressure. The y axis shows the difference between invasively measured PAPm and echocardiographically estimated PAPm according to the formulas of Aduen et al, 4 Chemla et al, 6 and Dabestani et al, 11 respectively. The x axis shows the average between invasively measured PAPm 
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The difference between the OR of PAPm estimated according to Aduen et al $ 25 mm Hg and the OR of TR Vmax > 2.8 m/sec was highly significant, favoring the PAPm model (P < .001). In addition to the examined formulas, we evaluated the OR for the presence of PH for right heart parameters, including tricuspid annular plane systolic excursion, right ventricular enlargement, and estimated RAP. Interestingly, an estimated RAP of 15 mm Hg was associated with a high OR of 13.8 (95% CI, 1.8-109.0; P = .013) with regard to the presence of PH. This result suggests that this parameter might add additional value when incorporated into a prediction algorithm.
In our cohort, using the TR Vmax method, eight patients (10.4%) were correctly classified as having no PH, and 50 patients (64.9%) were correctly classified as having PH. In comparison, when PAPm was estimated according to Aduen et al, 4 10 patients (13.0%) were correctly classified as having no PH, and 54 patients (70.1%) were correctly classified as having PH. In summary, 58 patients (75.3%) were correctly classified by the TR Vmax method and 64 patients ( 
DISCUSSION
At present, TR Vmax with a cutoff value of 2.8 m/sec is recommended for estimating the probability of PH in the current ESC guidelines. 1 The recommendation of using TR Vmax over methods estimating PAPm as the main variable for evaluating the echocardiographic probability of PH is due to concerns about the inaccuracies of RAP estimation and errors using derived variables. 1 However, this preference has not been fully substantiated by evidence. Our study reports the accuracy of various noninvasive methods for estimating PAPm.
The main findings in our study are as follows. First, although there are differences with regard to the precision of the algorithms estimating the presence or absence of a PH diagnosis, all methods are associated with certain inaccuracies. As shown in the Bland-Altman illustrations, in a few individuals, any of the examined formulas could be highly misleading. This possibility should always be kept in mind when discussing the likelihood of a diagnosis and the best feasible way to apply the various formulae in clinical practice.
Second, the method recommended in the guidelines (TR Vmax with a cutoff of 2.8 m/sec) is inferior to all analyzed methods that involve estimation of RAP with regard to the estimation of PAPm; more precisely, it is associated with a significantly lower AUC and a lower OR. Third, using PAPm by adding RAP to TR Pmean obtained from tracing the continuous-wave Doppler signal of the TR jet is superior to PAPsys with regard to estimating the likelihood of PH.
Fourth, direct methods for estimating PAPm had greater accuracy when estimating the likelihood of PH and a numerically stronger correlation with invasively measured PAPm compared with empirical methods.
Fifth, the PAT-derived method for estimating PAPm shows a weak correlation and should thus be used with caution. However, PAT < 100 msec indicates an increased likelihood of PH (OR, 4.8; 95% CI, 1.1-20.4; P = .034) and may therefore be useful in cases when no adequate TR signal can be obtained. In our study, an adequate TR signal was absent in 14.4% of cases. Of note, the proportion of examinations with missing TR signals might be reduced if agitated saline had been used, but this was not standard practice in our institutions.
Agreement between Noninvasive Estimation of PAPm and Invasive Measurement
As shown in the Bland-Altman plots (Figure 4) , the mean value of the difference between invasively measured PAPm and echocardiographically estimated PAPm was close to zero, indicating that none of the echocardiographic methods was associated with major systematic errors. However, for all noninvasive methods, the limits of agreement were not negligible, ranging from 630 mm Hg for the PAT method to 620 mm Hg for the other methods. These findings are in line with those of previous studies 4, 20 and indicate that clinically relevant over-and underestimation may eventually occur, regardless of which echocardiographic method is used, including outliers up to about 640 mm Hg. This result emphasizes the importance of identifying and applying the best Doppler-derived methods described in the literature. 4, 20 Moreover, these limitations make a good case for a multimodal approach consisting of clinical suspicion and a combination of several echocardiographic parameters to noninvasively estimate the likelihood of PH in an individual patient. To this point, our findings are in good agreement with the 2015 ESC guidelines on PH, which state that estimating PAP solely on the basis of Doppler transthoracic echocardiographic measurements is not suitable for screening mild, asymptomatic PH and therefore recommend other echocardiographic variables that might raise or reinforce suspicion of PH, independent of TR Vmax. 1 
Tracing the Continuous-Wave Doppler Envelope of TR versus PAT-Derived Estimation of PAPm
Echocardiographic estimation of PAPm by adding estimated RAP to TR Pmean obtained from tracing the continuous-wave Doppler signal of TR is reported to have satisfactory limits of agreement and correlation with PAPm measured by RHC. 3, 4 In our study, estimating PAPm using this method yielded the highest correlation with invasively measured PAPm and had the highest OR with regard to the presence of PH. Of note, a few authors report high rates (up to 39%) of weak or uninterpretable TR signals. 10 In our cohort, the method of Aduen et al 4 could not be applied, because of insufficient or absent TR signals in >10% of cases. This may limit the usefulness of the TR-based methods to estimate PAPm in some individuals. Several laboratories apply contrast (e.g., agitated saline), as it may improve the Doppler signal; however, as this was not standard practice in our hospitals, it is possible that additional accuracy of TR-based methods may be achievable over what our results suggest. As an alternative and TRindependent method, PAPm may also be calculated from PAT. 3, 11, 15 In contrast to previous reports, 11, 15 PAPm calculated using the PAT method correlated weakly (r = 0.384, P = .008) with invasively measured PAPm in our study. Moreover, a cutoff value of 25 mm Hg for PAPm estimated with the PAT method was not associated with an increased rate of invasively confirmed PH (P = .187). Such inferior precision may be a limitation inherent to the formula for calculating PAPm on the basis of PAT. In this formula, a positive value is subtracted from empirically determined constants (79 in cases of PAT > 120 msec and 90 in cases of PAT < 120 msec). Therefore, this method mathematically restricts PAPm to a maximum value of 79 (or 90) mm Hg, and PAPm values exceeding these values cannot occur by definition. Because these formulas were established in very small cohorts (e.g., 39 patients in the initial publication by Dabestani et al 11 ) , this shortcoming may not have become apparent in the original investigations.
Maximal Tricuspid Regurgitation Velocity
To avoid inaccuracies of RAP estimation, current ESC guidelines on PH recommend the use of TR Vmax with a cutoff value of 2.8 m/sec rather than using estimations of PAPsys or PAPm.
1 TR Vmax is also frequently applied to estimate the likelihood of PH as a continuous variable, such as in the DETECT study. 21 In our analysis, TR Vmax was associated with a significantly weaker correlation and a significantly lower AUC with regard to the presence of invasively confirmed PH compared with any other TR-derived method for estimating PAPm. Although various TR Vmax levels are associated with specific recommendations in the guidelines, 1 TR Vmax was not recommended to be used as a continuous variable. However, with regard to the presence of invasively confirmed PH, the categorical cutoff of TR Vmax > 2.8 m/sec resulted in a significantly lower OR than a PAPm cutoff of $25 mm Hg calculated using the method of Aduen et al 4 (P < .001; Table 2 ). To the best of our knowledge, a direct comparison between TR Vmax with a cutoff value of 2.8 m/sec and echocardiographic estimation of PAPm with a cutoff value of 25 mm Hg with regard to the diagnosis of PH has not been previously performed. As reported in a position paper by Badesch et al, 22 PH was arbitrarily defined as TR Vmax exceeding 2.8 m/sec during a meeting on PH held in Evian, France, in 1998. Therefore, although daily practice suggests that this cutoff was a good guess, whether this parameter is more accurate than alternative algorithms is somewhat questionable. So far, guidelines have not given preference to methods that include estimated RAP. Our data suggest that echocardiography provides only a rough approximation of invasively determined RAP (r = 0.592, P < .001). However, our data strongly suggest that calculating PAPm by adding RAP to TR Pmean is superior to the determination of TR Vmax alone. This applies to the correlation with invasive measurements of PAP, to ROC analysis, and to OR for the presence of PH. This result may be explained in part by the high OR obtained by estimating RAP in our study (Table 2) . Therefore, our data suggest that it may not be justified to assume that RAP is an additional source of error rather than of additive value (as mentioned in the current guidelines).
Of course, in cases of very high TR Vmax, the addition of RAP cannot further improve diagnostic accuracy. In our cohort, ''very high'' corresponded to TR Vmax of 3.4 m/sec, as this reflects PAPm of 25 mm Hg according to a correlation analysis (data not shown). Of note, in line with these observations, the European guidelines suggest this exact value as sufficient for assigning a high likelihood of PH, solely on the basis of TR Vmax (not requiring additional echocardiographic measurements).
Study Limitations
Our study had a few limitations. First, it was a retrospective database analysis of RHC and echocardiographic values. It therefore precludes a precise analysis of potential factors that led to omission of PAT measurements, which was determined only in half of the patients.
Second, only 24.4% of the patients in this analysis had no PH, according to the invasive measurement. This proportion reflects preselection under clinical conditions, which favor a high pretest probability before invasive measurement.
Third, although we limited the time interval between RHC and echocardiography to a maximum of 24 hours, the two examinations were not performed simultaneously. To address this potential shortcoming, we performed a correlation analysis for the subgroup of patients with delays of >12 but #24 hours between RHC and echocardiography and excluded time discrepancies as a major bias. Finally, although statistical comparisons demonstrated significant differences between the various methods, the limited number of additional, correctly classified patients suggests that additional studies are warranted to validate superiority of one method over another.
CONCLUSIONS
This analysis demonstrated that any of the examined methods exhibited inaccuracies that, in individual patients, may be misleading in assigning the correct diagnosis, or the decision to determine PAP invasively. However, noninvasive estimation of PAPm by adding RAP to TR Pmean (calculated from the TR time-velocity integral) had the best correlation with invasively measured PAPm and the highest OR with regard to the occurrence of PH. Measurement of PAPsys or simple measurement of TR Vmax without the addition of RAP were associated with inferior performance. The PAT-derived method for estimating PAPm exhibited only a weak correlation with invasively measured PAPm; however, a PAT of <100 msec was a signal for the presence of PH. Our study implies that PAPm, and the practical echocardiographic methods that allow this variable to be determined, may deserve more attention.
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